EU approves Sanofi’s Dupixent for the treatment of “light smokers”
Sanofi and partner Regeneron on Wednesday won European Union approval for wider use of the injectable drug Dupixent in patients with chronic lung disease, a rare case of the EU approving a drug faster than the US.
ПОПУЛЯРНЫЕ ПОСТЫ
Putin may discuss Ukraine peace deal with Trump
Ноябрь 22, 2024
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ